Paxman AB (PAX)

Currency in SEK
50.60
+1.20(+2.43%)
Closed·

PAX Earnings

Latest Release
Feb 27, 2026
EPS / Forecast
-0.40 / 0.20
Revenue / Forecast
84.2M / 91.85M
EPS Revisions
Last 90 days
Release Date
Period End
EPS
/Forecast
Revenue
/Forecast
EPS Surprise %
Revenue Surprise %
Reaction
2026/03--/----/94.60M----Free Sign Up
2025/12-0.400/0.20084.20M/91.85M-300%-8.33%Free Sign Up
2025/090.100/0.20086.95M/96.75M-50%-10.13%Free Sign Up
2025/06-0.100/--74.95M/83.60M---10.35%Free Sign Up
2025/03-0.290/--69.62M/------Free Sign Up
2024/120.600/0.70066.20M/72.30M-14.29%-8.44%Free Sign Up
2024/090.200/0.60064.80M/69.20M-66.67%-6.36%Free Sign Up
2024/060.500/0.50063.00M/63.00M0%0%Free Sign Up
2024/030.200/0.20057.00M/57.00M0%0%Free Sign Up
2023/12-0.100/-0.10056.00M/56.00M0%0%Free Sign Up

All numbers in SEK

Paxman AB Earnings Call Summary for Q3/2025

  • Paxman AB reported 34% YoY revenue growth to SEK 86.9M in Q3 2025, despite stock falling 4.95% due to SEK 20M cash outflow and slower insurance-based billing adoption
  • Integration of Dignitana expanded market presence but added SEK 7.5M in costs, with total revenue comprising SEK 21M from acquisitions and SEK 1.1M from organic growth
  • Q3 financial results showed EBITDA of SEK 7.8M (9% margin), operating profit of SEK 1M, and a cash position of SEK 130M despite significant outflows
  • Company expects substantial growth in 2026, with FDA clearance for its new CIPN product anticipated in March 2026, showing impressive clinical results
  • CEO Richard Paxman expressed optimism about the company's position, focusing on transitioning to an insurance-based billing model and continued investment in reimbursement
Last Updated: 2025-11-14, 03:46 a/m
Read Full Transcript

FAQ

What Is Paxman's Earnings Per Share (TTM)?

The Paxman EPS (TTM) is -0.72.

When Is The Next Paxman Earnings Date?

Paxman will release its next earnings report on May 21, 2026.

How Did Paxman React to the Company's Latest Earnings Report?

Paxman reported a -300% EPS surprise and a -8.33% revenue surprise, comparing the latest report against analyst forecasts. The stock price changed by 5.18%, reflecting the market's response to the earnings results.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.